Results 201 to 210 of about 83,092 (356)

Immune remodeling and metabolic reprogramming in chronic fatigue: insights into GPCR signaling and epigenetic regulation. [PDF]

Front Immunol
Hu Z, Wang J, Ma S, Zhuang J, Shi J, Zhu Y.   +5 more
europepmc   +1 more source

Sequence of Immunological Events During IgE‐Mediated Allergic Reactions to Food

Allergy, EarlyView.
ABSTRACT Food allergies (FA) represent a significant global health burden. Upon allergen re‐exposure, allergic patients exhibit a sequence of symptoms that vary in terms of affected organ systems, severity, time of onset and allergen reactivity thresholds.
N. A. Nagy, D. Schnoegl, V. Houghton, L. O'Mahony, A. F. Santos, E. F. Knol, A. Kuehn, T. Eiwegger   +7 more
wiley   +1 more source

The Selectivity Implications of Docking Libraries with Greater and Lesser Similarities to Bio-like Molecules. [PDF]

J Med Chem
Hall BW, Sakamoto K, Huang XP, Irwin JJ, Shoichet BK, Roth BL.   +5 more
europepmc   +1 more source

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology, EarlyView.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

Regulation of GPCR activity, trafficking and localization by GPCR‐interacting proteins [PDF]

, 2011
Ana C. Magalhães, Henry A. Dunn, Stephen S. G. Ferguson   +2 more
openalex   +1 more source

Evidence that 5‐HT2A receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non‐psychedelic drugs

British Journal of Pharmacology, EarlyView.
Background and Purpose Serotonergic psychedelic drugs are under investigation as therapies for various psychiatric disorders, including major depression. Although serotonergic psychedelic drugs are 5‐HT2A receptor agonists, some such agonists are not psychedelic, potentially due to differences in 5‐HT2A receptor ligand bias or signalling efficacy. Here,
Aurelija Ippolito, Sridhar Vasudevan, Shaun Hurley, Gary Gilmour, Frederick Westhorpe, Grant Churchill, Trevor Sharp   +6 more
wiley   +1 more source

Generative Principal Component Regression via Variational Inference. [PDF]

IEEE Trans Signal Process
Talbot A, Keller CJ, Trevino C, Carlson DE, Dammer EB, Johnson ECB, Wingo TS, Kotlar AV.   +7 more
europepmc   +1 more source

Homology modeling of GPCR proteins based upon 3-dimensional structures of agonist, partial inverse agonist, antagonist and antagonist-mimic types

, 2014
美里 松岡
openalex   +1 more source

Compartmentalisation in cAMP signalling: A phase separation perspective

British Journal of Pharmacology, EarlyView.
Cells rely on precise spatiotemporal control of signalling pathways to ensure functional specificity. The compartmentalisation of cyclic AMP (cAMP) and protein kinase A (PKA) signalling enables distinct cellular responses within a crowded cytoplasmic space.
Milda Folkmanaite, Manuela Zaccolo
wiley   +1 more source

A novel fusion tool to enable G protein-coupled receptor structure determination. [PDF]

Acta Crystallogr D Struct Biol
Shah NR, Oosterlaken M, Bisson C, Bertinelli M, Churchill-Angus AM, Hutchin A, Kopec J, Kotov V, McFarlane CR, Griss Pascualli E, Pavic A, Zebisch M, Fiez-Vandal C, Fabini E, Duclos S.   +14 more
europepmc   +1 more source